Judith M Martin Selected Research

Judith M Martin Research Topics

Disease

9	Otitis Media 09/2023 - 11/2014
7	Human Influenza (Influenza) 06/2023 - 10/2016
6	COVID-19 07/2023 - 10/2021
5	Infections 01/2022 - 11/2004
5	Pharyngitis (Sore Throat) 11/2020 - 12/2003
4	Communicable Diseases (Infectious Diseases) 09/2023 - 11/2012
4	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 01/2019
4	Sinusitis 01/2023 - 11/2019
3	Pneumonia (Pneumonitis) 01/2023 - 10/2007
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 09/2021
2	Breakthrough Infections 01/2022 - 10/2021
2	Pyelonephritis 11/2020 - 01/2019
2	Fever (Fevers) 08/2012 - 04/2011
1	Bacteriuria 01/2023
1	Asymptomatic Infections 11/2021
1	Coinfection 01/2021
1	Glomerulonephritis 11/2020
1	Cicatrix (Scar) 11/2020
1	Cystitis 01/2019
1	Body Weight (Weight, Body) 01/2017
1	Diarrhea 01/2017
1	Dermatitis 01/2017
1	Candidiasis (Moniliasis) 01/2017
1	Aspergillosis 01/2017
1	Invasive Candidiasis 01/2017
1	Sepsis (Septicemia) 03/2016
1	Pyuria 01/2016
1	Rubella (German Measles) 08/2012
1	Chickenpox 08/2012
1	Mumps 08/2012
1	Measles 08/2012
1	Hepatitis A (Hepatitis, Infectious) 08/2012
1	Exanthema (Rash) 08/2012
1	Bacterial Meningitis 04/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2007

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 07/2023 - 08/2012
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2005
4	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 10/2021
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 12/2003
4	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2018 - 12/2016
3	BNT162 VaccineIBA 07/2023 - 10/2021
3	Ad26COVS1IBA 07/2023 - 10/2021
3	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	Conjugate VaccinesIBA 03/2018 - 08/2012
3	Amoxicillin (Wymox)FDA LinkGeneric 10/2017 - 12/2016
2	Neutralizing AntibodiesIBA 07/2023 - 10/2016
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	CytokinesIBA 01/2021 - 11/2019
2	Erythromycin (Erycette)FDA LinkGeneric 02/2007 - 12/2003
2	MacrolidesIBA 02/2007 - 12/2003
2	ElementsIBA 02/2007 - 12/2003
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 07/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	Immunoglobulin A (IgA)IBA 06/2023
1	Immunoglobulin M (IgM)IBA 06/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	AntibodiesIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 12/2021
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	16S Ribosomal RNAIBA 11/2019
1	CXC ChemokinesIBA 01/2019
1	InterferonsIBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	ChemokinesIBA 01/2019
1	ProcalcitoninIBA 01/2019
1	LigandsIBA 01/2019
1	Cefdinir (Omnicef)FDA LinkGeneric 10/2017
1	Hemagglutinins (Hemagglutinin)IBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Voriconazole (Vfend)FDA LinkGeneric 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	liposomal amphotericin B FDA Link 03/2016
1	leukocyte esteraseIBA 01/2016
1	AntigensIBA 06/2014
1	AntipyreticsIBA 08/2012
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2011
1	Valganciclovir FDA Link 05/2011
1	Glucose (Dextrose)FDA LinkGeneric 04/2011
1	CCCGGG-specific type II deoxyribonucleasesIBA 02/2007
1	DNA (Deoxyribonucleic Acid)IBA 02/2007
1	FluoroquinolonesIBA 04/2005
1	Anti-Infective Agents (Microbicides)IBA 11/2004

Therapy/Procedure

6	Therapeutics 09/2023 - 03/2016
1	Duration of Therapy 01/2023
1	Intramuscular Injections 11/2021
1	Injections 11/2021
1	Middle Ear Ventilation (Tympanostomy) 01/2021
1	Catheters 03/2016
1	Central Venous Catheters 03/2016
1	Transplantation 10/2007
1	Induction Chemotherapy 10/2007